<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0050">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Mayer</surname>
    <given-names>A. M. S.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Guerrero</surname>
    <given-names>A. J.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rodríguez</surname>
    <given-names>A. D.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Taglialatela-Scafati</surname>
    <given-names>O.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Nakamura</surname>
    <given-names>F.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Fusetani</surname>
    <given-names>N.</given-names>
   </name>
  </person-group> (
  <year>2019</year>). 
  <article-title>Marine pharmacology in 2014–2015: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, antiviral, and anthelmintic activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action</article-title>. 
  <source>
   <italic>Marine Drugs</italic>
  </source>, 
  <volume>18</volume>(
  <issue>1</issue>), 
  <fpage>5</fpage>
  <pub-id pub-id-type="doi">10.3390/md18010005</pub-id>
 </mixed-citation>
</ref>
